These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25963773)

  • 1. Drug Familiarization and Therapeutic Misconception Via Direct-to-Consumer Information.
    Bélisle-Pipon JC; Williams-Jones B
    J Bioeth Inq; 2015 Jun; 12(2):259-67. PubMed ID: 25963773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating Direct-to-Consumer Drug Information: A Case Study of Eli Lilly's Canadian 40over40 Erectile Dysfunction Campaign.
    Pipon JC; Williams-Jones B
    Healthc Policy; 2015 May; 10(4):16-23. PubMed ID: 26142356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can direct-to-consumer advertising of prescription drugs be effectively regulated?
    Lexchin J; Menkes DB
    N Z Med J; 2019 Jun; 132(1496):59-65. PubMed ID: 31170134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H
    Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Marketing in the United States, 1997-2016.
    Schwartz LM; Woloshin S
    JAMA; 2019 Jan; 321(1):80-96. PubMed ID: 30620375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicines Information and the Regulation of the Promotion of Pharmaceuticals.
    Leonardo Alves T; Lexchin J; Mintzes B
    Sci Eng Ethics; 2019 Aug; 25(4):1167-1192. PubMed ID: 29721844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a direct-to-consumer information campaign on prescription patterns for overactive bladder.
    Zaitsu M; Yoo BK; Tomio J; Nakamura F; Toyokawa S; Kobayashi Y
    BMC Health Serv Res; 2018 May; 18(1):325. PubMed ID: 29724205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feeling Is Believing: Evaluative Conditioning and the Ethics of Pharmaceutical Advertising.
    Biegler P; Vargas P
    J Bioeth Inq; 2016 Jun; 13(2):271-9. PubMed ID: 26818244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA.
    Mintzes B; Barer ML; Kravitz RL; Bassett K; Lexchin J; Kazanjian A; Evans RG; Pan R; Marion SA
    CMAJ; 2003 Sep; 169(5):405-12. PubMed ID: 12952801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials.
    Arnold DG; Oakley JL
    J Health Polit Policy Law; 2019 Oct; 44(5):765-787. PubMed ID: 31199865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Mintzes B
    Int J Health Policy Manag; 2016 Feb; 5(5):329-31. PubMed ID: 27239883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A compromise too far: a review of Canadian cases of direct-to-consumer advertising regulation.
    Lexchin J; Mintzes B
    Int J Risk Saf Med; 2014; 26(4):213-25. PubMed ID: 25420763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease.
    Eisenberg MD; Singh Y; Sood N
    JAMA Health Forum; 2022 Aug; 3(8):e222570. PubMed ID: 36200632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct-to-consumer advertising under the radar: the need for realistic drugs policy in Australia.
    Mackenzie FJ; Jordens CF; Ankeny RA; McPhee J; Kerridge IH
    Intern Med J; 2007 Apr; 37(4):224-8. PubMed ID: 17388861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct-to-physician and direct-to-consumer advertising: Time to have stringent regulations.
    Kannan S; Gowri S; Tyagi V; Kohli S; Jain R; Kapil P; Bhardwaj A
    Int J Risk Saf Med; 2015; 27(2):77-83. PubMed ID: 26410010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
    Mintzes B; Barer M; Lexchin J; Bassett KL
    Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in direct-to-consumer advertising of prescription contraceptives.
    Wu MH; Bartz D; Avorn J; Seeger JD
    Contraception; 2016 May; 93(5):398-405. PubMed ID: 26808088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of direct-to-consumer drug advertising during the Super Bowl on drug utilization.
    Gray MP; San-Juan-Rodriguez A; Chen N; Good CB; Hernandez I
    Res Social Adm Pharm; 2020 Aug; 16(8):1136-1139. PubMed ID: 31864886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
    Mackey TK
    Int J Health Policy Manag; 2016 Feb; 5(4):271-4. PubMed ID: 27239871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complaints addressed by regulatory authorities in drug advertising targeted at consumers: Cases across three, different countries.
    Song SY; Lee JH; Kim SC; Choi JW; Bae J; Kim E
    Res Social Adm Pharm; 2019 Oct; 15(10):1274-1279. PubMed ID: 30552049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.